粤港澳大湾区生物医药产业发展分析及建议 点击下载
| 论文标题： | 粤港澳大湾区生物医药产业发展分析及建议 |
| 英文标题： | |
| 中文摘要： | 目的：为进一步促进粤港澳大湾区生物医药产业的高质量发展提供参考。方法：通过概括粤港澳大湾区生物医药行业的发展现状与发展环境，介绍国外先进生物医药产业园区建设经验，梳理粤港澳大湾区生物医药产业面临的问题和挑战，提出相应的对策与建议。结果与结论：粤港澳大湾区有多重政策支持，有利于生物医药产业发展；产业链条完整，生物产业规模优势日益呈现；创新成果丰硕，研发投入全国领先；医药制造业发达，医疗资源总量多；金融优势明显，制度创新有助于生物医药产业发展；国际化进程领先，利于持续促进对外合作。但与国外先进的生物医药产业园区相比，粤港澳大湾区在管理模式、服务模式“、产-学-研”合作方面还稍有不足，也面临着三地法律体系和行业规范有待进一步衔接、人才存在缺口、产业链不够完善、新药研发支持不足“、产-学-研”合作亟待加强、金融支持水平亟待提升等问题和挑战。据此，笔者建议要消除制度障碍，推动法律体系和行业规范的衔接；创新人才政策，持续吸引优秀研发人才入驻；引入龙头企业，完善产业链条；打通临床试验渠道，提升科研成果转化效率；强化“产-学-研”合作，推动生物医药创新能力提升；善用金融支持，助力生物医药产业企业迅速崛起，以推动粤港澳大湾区生物医药产业高质量发展。 |
| 英文摘要： | OBJECTIVE：To provide reference for furthe r promoting the high-quality development of the biomedical industry in Guangdong-Hong Kong-Macao Greater Bay Area. METHODS ：Through summarizing the development status and development environment of the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area ，the construction experience of foreign advanced biomedical industrial park was introduced ，and the problems and challenges faced by the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area were sorted out so as to put forward relevant countermeasures and suggestions. RESULTS & CONCLUSIONS ：Guangdong-Hong Kong-Macao Greater Bay Area has received multiple policy support，which is conducive to the development of biomedical industry. The industrial chain is complete ，and the scale advantage of biological industry is showing day by day. Biological industry has achieved fruitful innovation achievement ，and its R&D investment is in the leading position in the country. The pharmaceutical manufacturing industry is developed and the total amount of medical resources is large. The financial advantages are obvious ，and institutional innovation is conducive to the development of biomedical industry. The process of internationalization takes the leading place ，which is conducive to continuously promoting foreign cooperation. However ，compared with foreign advanced biomedical industrial parks ，Guangdong-Hong Kong-Macao Greater Bay Area still has some deficiencies in management mode ，service mode and “industry-university-institute”cooperation. It also faces the following problems that the legal systems and industry norms of the three places need to be further connected ；there is a talent gap ；the industrial chain is not perfect ；the support for new drug R&D is insufficient ；the“industry-university-institute” cooperation needs to be strengthened ；the level of financial support needs to be improved. Accordingly ，it is recommended to break down institutional barriers ，and promote the connection between the legal system and industry norms ；innovate talent policies ，and continue to attract excellent R&D talents ；introduce leading companies ，and improve the industrial chain ；open up clinical trial channels and promote the transformation efficiency of scientific research achievements ；strengthen“industry-university-institute” cooperation，and promote the improvement of biomedical innovation ability ；make good use of financial support to help the rapid rise of biomedical industry enterprises ，so as to promote the high-quality development of biomedical industry in Guangdong-Hong Kong-Macao Greater Bay Area. |
| 期刊： | 2021年第32卷第21期 |
| 作者： | 梁云，岳霄霄，邵蓉 |
| 英文作者： | LIANG Yun，YUE Xiaoxiao ，SHAO Rong |
| 关键字： | 粤港澳大湾区；生物医药产业；发展；建议 |
| KEYWORDS： | Guangdong-Hong Kong-Macao Greater Bay Area ；Biomedical industry ；Development；Suggestion |
| 总下载数： | 81次 |
| 本日下载数： | 2次 |
| 本月下载数： | 81次 |
| 文件大小： | 619.60Kb |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！